Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced?

scientific article published on 9 August 2013

Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced? is …
instance of (P31):
scholarly articleQ13442814
editorialQ871232

External links are
P356DOI10.1136/ANNRHEUMDIS-2013-203911
P698PubMed publication ID23933626
P5875ResearchGate publication ID255734876

P2093author name stringPatrick H Dessein
Anne G Semb
P2860cites workWhat is the best strategy for reducing deaths from heart disease?Q24792163
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritisQ33505914
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesQ34154032
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severityQ34238357
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular diseaseQ34684331
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studiesQ34889152
Heart disease and rheumatoid arthritis: understanding the risksQ35019085
Systematic review and meta-analysis of methotrexate use and risk of cardiovascular diseaseQ35377706
Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritisQ35777047
Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritisQ36098818
Genetic markers of cardiovascular disease in rheumatoid arthritis.Q36165202
Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysisQ36907729
Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular diseaseQ37353240
Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessmentQ37533298
High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysisQ37775403
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectivesQ37812524
Cardiovascular risk and rheumatoid arthritis--the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammationQ37900782
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constitutedQ38018762
The widening mortality gap between rheumatoid arthritis patients and the general populationQ38459919
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) StudyQ39863525
Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specificQ39905586
Biomarkers in clinical trials: can we move from fortune telling to disease profiling?Q43541434
Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint diseaseQ44204800
Carotid plaque characteristics and disease activity in rheumatoid arthritisQ46487876
Preclinical carotid atherosclerosis in patients with rheumatoid arthritisQ46954458
The carotid artery atherosclerosis burden and its relation to cardiovascular risk factors in black and white Africans with established rheumatoid arthritis: a cross-sectional study.Q47426561
Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendationsQ48008568
Independent relationship between circulating resistin concentrations and endothelial activation in rheumatoid arthritis.Q50958991
How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts.Q52216715
Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis.Q53101781
Carotid Intima-Media Thickness Predicts the Development of Cardiovascular Events in Patients with Rheumatoid ArthritisQ57307089
A Negative Carotid Plaque Area Test Is Superior to Other Noninvasive Atherosclerosis Studies for Reducing the Likelihood of Having Underlying Significant Coronary Artery DiseaseQ58585198
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectrheumatoid arthritisQ187255
cardiovascular diseaseQ389735
P304page(s)1743-1746
P577publication date2013-08-09
P1433published inAnnals of the Rheumatic DiseasesQ4767876
P1476titleCould cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced?
P478volume72

Reverse relations

cites work (P2860)
Q33790971Adiponectin and atherosclerosis in rheumatoid arthritis
Q87050900Age impacts on the independent relationships of leptin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study
Q47940789Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China
Q26851800Cardiovascular disease risk amongst African black patients with rheumatoid arthritis: the need for population specific stratification
Q34563216Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
Q35222947Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study
Q41868896Enhanced cardiovascular risk in rheumatoid arthritis: elucidation, assessment, and management
Q57299625Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project
Q33750044HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
Q35217530Kidney function, endothelial activation and atherosclerosis in black and white Africans with rheumatoid arthritis
Q37433269Marked independent relationship between circulating interleukin-6 concentrations and endothelial activation in rheumatoid arthritis
Q38628320Nurses' Role in Cardiovascular Risk Assessment and Management in People with Inflammatory Arthritis: A European Perspective
Q35126137Retinol binding protein 4 concentrations relate to enhanced atherosclerosis in obese patients with rheumatoid arthritis
Q41514844Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry

Search more.